Kejako Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 2

Kejako General Information

Description

Developer of a personalized, no-cut treatment designed for reversing presbyopia. The company uses advanced numerical simulations to adapt to patient biometry and presbyopia state and predict optimal treatment patterns and performance, enabling healthcare providers to plan and control the customized procedure.

Contact Information

Website
www.kejako.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Route de la Galaise 34
  • Plan-les-Ouates
  • 1228 Geneva
  • Switzerland
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • Route de la Galaise 34
  • Plan-les-Ouates
  • 1228 Geneva
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kejako Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2019 Completed Generating Revenue
2. Accelerator/Incubator 30-Oct-2018 $816K Completed Generating Revenue
1. Seed Round 21-Mar-2018 $816K $816K Completed Generating Revenue
To view Kejako’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Kejako Patents

Kejako Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3378439-A1 Intracorneal implant Inactive 24-Mar-2017
EP-3600153-A1 Intracorneal implant Inactive 24-Mar-2017
WO-2018172553-A1 Intracorneal implant Inactive 24-Mar-2017
AU-2018238718-A1 Iris cover implant Inactive 24-Mar-2017
EP-3378440-A1 Iris cover implant Inactive 24-Mar-2017 A61F2/14
To view Kejako’s complete patent history, request access »

Kejako Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kejako Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Fongit Accelerator/Incubator Minority
EFI Lake Geneva Ventures Venture Capital Minority
To view Kejako’s complete investors history, request access »

Kejako FAQs

  • When was Kejako founded?

    Kejako was founded in 2015.

  • Where is Kejako headquartered?

    Kejako is headquartered in Geneva, Switzerland.

  • What is the size of Kejako?

    Kejako has 6 total employees.

  • What industry is Kejako in?

    Kejako’s primary industry is Therapeutic Devices.

  • Is Kejako a private or public company?

    Kejako is a Private company.

  • What is Kejako’s current revenue?

    The current revenue for Kejako is .

  • How much funding has Kejako raised over time?

    Kejako has raised $816K.

  • Who are Kejako’s investors?

    Fongit and EFI Lake Geneva Ventures have invested in Kejako.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process